Sowell Financial Services LLC Navidea Biopharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

  • $2.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$1.55 - $2.15 $17,344 - $24,058
-11,190 Closed
0 $0
Q4 2020

Jan 13, 2021
SELL
$1.88 - $2.84 $82 - $124
-44 Reduced 0.39%
11,190 $24,000
Q3 2020

Nov 12, 2020
SELL
$2.69 - $4.95 $269 - $495
-100 Reduced 0.88%
11,234 $30,000
Q2 2020

Aug 13, 2020
BUY
$0.7 - $4.16 $5,960 - $35,422
8,515 Added 302.06%
11,334 $45,000
Q3 2019

Nov 14, 2019
BUY
$0.5 - $0.91 $1,409 - $2,565
2,819 New
2,819 $2,000

Others Institutions Holding NAVB

# of Institutions
3
Shares Held
10.4K
Call Options Held
0
Put Options Held
0
View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

NAVB Quotes by TradingView
  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email